Computerized testing to detect cognitive decline in biomarker‐confirmed Alzheimer’s disease: Longitudinal findings from the ARMADA study.

The NIHTB detects cross-sectional impairment in episodic memory, attention, executive functions and working memory and longitudinal change in processing speed, working memory and auditory word comprehension in prodromal-to-mild AD. These findings further support the use of the NIHTB in AD research, but also imply that the optimal NIHTB composite to detect cognitive decline may differ across AD clinical stages.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.092380
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Computerized testing to detect cognitive decline in biomarker‐confirmed Alzheimer’s disease: Longitudinal findings from the ARMADA study.

Sandra Weıntraub, Hiroko H. Dodge, Roos J. Jutten, Emily Ho et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Computerized testing to detect cognitive decline in biomarker‐confirmed Alzheimer’s disease: Longitudinal findings from the ARMADA study.

Sandra Weıntraub, Hiroko H. Dodge, Roos J. Jutten, Emily Ho, Carol A. Van Hulle, Tatiana Karpouzian‐Rogers, Richard C Gershon, Cindy J. Nowinski, Dorene M. Rentz
article en

Abstract

The NIHTB detects cross-sectional impairment in episodic memory, attention, executive functions and working memory and longitudinal change in processing speed, working memory and auditory word comprehension in prodromal-to-mild AD. These findings further support the use of the NIHTB in AD research, but also imply that the optimal NIHTB composite to detect cognitive decline may differ across AD clinical stages.

Alzheimer s & DementiaVol. 20(S3)
Northwestern University (US), Brigham and Women's Hospital (US), University of Wisconsin–Madison (US), Harvard University (US), Massachusetts General Hospital (US)
Quality Education
Openalex Percentile: Top 66%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Computerized testing to detect cognitive decline in biomarker‐confirmed Alzheimer’s disease: Longitudinal findings from the ARMADA study. — Sandra Weıntraub, Hiroko H. Dodge, et al. · Alzheimer s & Dementia (2024) | TGRS Research Map | TGRS